Skip to main content
Health Services Research logoLink to Health Services Research
. 1993 Dec;28(5):543–561.

The use of health services by women with HIV infection.

F J Hellinger 1
PMCID: PMC1069963  PMID: 8270420

Abstract

OBJECTIVE. The purpose of this study is to determine whether women who have been diagnosed with HIV utilize the same volume of medical care services as men who have been diagnosed with HIV. DATA SOURCES. This study uses data from the first wave of interviews of the AIDS Cost and Service Utilization Survey (ACSUS) conducted between May and July of 1991. The first wave of interviews involved 1,949 adults and adolescents, of whom 359 were women. STUDY DESIGN. The ACSUS sample was selected from 26 sites (hospitals, clinics, and physician offices) in ten cities chosen from the 25 cities with the most AIDS cases. Cities are located throughout the nation, and in low, medium, and high prevalence areas. The sites in each city are generally those that treat the highest number of persons with HIV infection. Patients at each site were chosen using disease stage (asymptomatic, symptomatic, and AIDS) and gender as the selection criteria. Utilization equations are estimated for AZT use, outpatient care, and hospitalization. DATA COLLECTION. The ACSUS involves six in-person interviews over an 18-month period. Interviews include questions about the use of medical and support services, insurance status, functional status, and barriers to care during the prior three-month period. PRINCIPAL FINDINGS. A male injection drug user (IDU) with AIDS is 20 percent more likely to be hospitalized than a woman with AIDS, and the hospital cost of treating a male IDU with AIDS is $9,180 more per year than the hospital cost of treating a woman with AIDS. CONCLUSIONS. This study shows that, even after being diagnosed and after having accessed the medical care system, women with AIDS receive fewer services than men with AIDS.

Full text

PDF
547

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews R. M., Keyes M. A., Fanning T. R., Kizer K. W. Lifetime Medicaid service utilization and expenditures for AIDS in New York and California. J Acquir Immune Defic Syndr. 1991;4(10):1046–1058. [PubMed] [Google Scholar]
  2. Bennett C. L., Cvitanic M., Pascal A. The costs of AIDS in Los Angeles. J Acquir Immune Defic Syndr. 1991;4(2):197–203. [PubMed] [Google Scholar]
  3. Bennett C. L., Garfinkle J. B., Greenfield S., Draper D., Rogers W., Mathews C., Kanouse D. E. The relation between hospital experience and in-hospital mortality for patients with AIDS-related PCP. JAMA. 1989 May 26;261(20):2975–2979. [PubMed] [Google Scholar]
  4. Bennett C. L., Pascal A., Cvitanic M., Graham V., Kitchens A., DeHovitz J. A. Medical care costs of intravenous drug users with AIDS in Brooklyn. J Acquir Immune Defic Syndr. 1992;5(1):1–6. [PubMed] [Google Scholar]
  5. Farizo K. M., Buehler J. W., Chamberland M. E., Whyte B. M., Froelicher E. S., Hopkins S. G., Reed C. M., Mokotoff E. D., Cohn D. L., Troxler S. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA. 1992 Apr 1;267(13):1798–1805. [PubMed] [Google Scholar]
  6. Hellinger F. J. Forecasts of the costs of medical care for persons with HIV: 1992-1995. Inquiry. 1992 Fall;29(3):356–365. [PubMed] [Google Scholar]
  7. Minkoff H. L., DeHovitz J. A. Care of women infected with the human immunodeficiency virus. JAMA. 1991 Oct 23;266(16):2253–2258. [PubMed] [Google Scholar]
  8. Moore R. D., Hidalgo J., Sugland B. W., Chaisson R. E. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med. 1991 May 16;324(20):1412–1416. doi: 10.1056/NEJM199105163242006. [DOI] [PubMed] [Google Scholar]
  9. Mor V., Fleishman J. A., Dresser M., Piette J. Variation in health service use among HIV-infected patients. Med Care. 1992 Jan;30(1):17–29. doi: 10.1097/00005650-199201000-00002. [DOI] [PubMed] [Google Scholar]
  10. Scitovsky A. A. Studying the cost of HIV-related illnesses: reflections on the moving target. Milbank Q. 1989;67(2):318–344. [PubMed] [Google Scholar]
  11. Stein M. D., Piette J., Mor V., Wachtel T. J., Fleishman J., Mayer K. H., Carpenter C. C. Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons. J Gen Intern Med. 1991 Jan-Feb;6(1):35–40. doi: 10.1007/BF02599388. [DOI] [PubMed] [Google Scholar]
  12. Stone V. E., Seage G. R., 3rd, Hertz T., Epstein A. M. The relation between hospital experience and mortality for patients with AIDS. JAMA. 1992 Nov 18;268(19):2655–2661. [PubMed] [Google Scholar]

Articles from Health Services Research are provided here courtesy of Health Research & Educational Trust

RESOURCES